TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pfizer Anti-Infectives AB
Closing information (x1000 EUR)
| Closing information | 2023/11 | 2022/11 | 2021/11 |
| Turnover |
185,053
|
123,850
|
32,288 |
| Financial expenses |
0
|
43
|
124 |
| Earnings before taxes |
88,416
|
37,997
|
-55,413 |
| EBITDA |
91,235
|
43,458
|
-49,507 |
| Total assets |
219,895
|
144,661
|
111,634 |
| Current assets |
5,826
|
10,283
|
21,266 |
| Current liabilities |
66,150
|
57,263
|
50,547 |
| Equity capital |
153,745
|
87,398
|
61,087 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Solvency |
69.9%
|
60.4%
|
54.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
47.8%
|
30.7%
|
-171.6% |
| Return on assets (ROA) |
40.2%
|
26.3%
|
-49.5% |
| Current ratio |
8.8%
|
18.0%
|
42.1% |
| Return on equity (ROE) |
57.5%
|
43.5%
|
-90.7% |
| Change turnover |
66,666
|
93,601
|
-117,014 |
| Change turnover % |
56%
|
309%
|
-78% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.